Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2006-11-02
2011-12-06
Wen, Sharon (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S157100, C424S130100
Reexamination Certificate
active
08071101
ABSTRACT:
The present invention includes a pharmaceutical compositions and methods for treating diseases associated with gluten intolerance in a patient, comprising: administering to the patient an effective amount of an antibody having specific activity against gluten or gluten-derived peptides. Such diseases include, for example, celiac disease and dermatitis herpetiformis.
REFERENCES:
patent: 2004/0047856 (2004-03-01), Williams et al.
patent: 2005/099753 (2005-10-01), None
Warny, M., et al., “Bovine Immunoglobulin Concentrate—Clostridium difficileRetainsC difficileToxin Neutralising Activity After Passage Through the Human Stomach and Small Intestine,” Gut, 44: 212-217 (1999).
Bernassola, Francesca, et al., “Role of Transglutaminase 2 in Glucose Tolerance: Knockout Mice Studies and a Putative Mutation in a MODY Patient,” The FASEB Journal, 16: 1371-1378 (2002).
Shan, Lu, et al., “Structural Basis for Gluten Intolerance in Celiac Sprue,” Science, 297: 2275-2279 (2002).
Arentz-Hansen, E H, et al., “Production of a Panel of Recombinant Gliadins for the Characterisation of T Cell Reactivity in Coeliac Disease,” Gut, 46: 46-51 (2000).
Ellis, H J, et al., “Measurement of Gluten Using a Monoclonal Antibody to a Coeliac Toxic Peptide of a Gliadin,” Gut, 43: 190-195 (1998).
Jabri, Bana, et al., “Innate and Adaptive Immunity: the Yin and Yang of Celiac Disease,” Immunological Reviews, 206: 219-231 (2005).
Green, Peter H.R., et al., “Celiac Disease,” Annu. Rev. Med., 57: 14.1-14.15 (2006).
Freedman, Daniel J., et al., “Milk Immunoglobulin with Specific Activity Against Purified Colonization Factor Antigens Can Protect Against Oral Challenge with EnterotoxigenicEscherichia coli,” J. Infectious Diseases, 177: 662-7 (1998).
Ontsouka, C.E., et al., “Fractionized Milk Composition During Removal of Colostrum and Mature Milk,” J. Dairy Sci., 86: 2005-2011 (2003).
Mitra, AK, et al., “Hyperimmune Cow Colostrum Reduces Diarrhoea Due to Rotavirus: a Double-Blind, Controlled Clinical Trial,” Acta Paediatr., 84: 996-1001 (1995).
Matysiak-Budnik, Tamara, et al., “Limited Efficiency of Prolyl-Endopeptidase in the Detoxification of Gliadin Peptides in Celiac Disease,” Gastroenterology, 129: 786-796 (2005).
Tacket, Carol O., et al., “Efficacy of Bovine Milk Immunoglobulin Concentrate in Preventing Illness AfterShigella flexneriChallenge,” Am. J. Trop. Med. Hyg., 47(3): 276-283 (1992).
Shin, Ji-Hyun, et al., “Production of Anti-Helicobacter pyloriUrease-Specific Immunoglobulin in Egg Yolk Using an Antigenic Epitope ofH. pyloriUrease,” J. Medical Microbiology, 53: 31-34 (2004).
Sarker, Shafiqul A., et al., “Randomized, Placebo-Controlled, Clinical Trial of Hyperimmunized Chicken Egg Yolk Immunoglobulin in Children with Rotavirus Diarrhea,” J. Pediatric Gastroenterology and Nutrition, 32(1): 19-25 (2001).
Weiss, Joseph B., et al., “Gluten-Sensitive Enteropathy,” J. Clin. Invest., 72: 96-101 (1983).
Ungar, Beth L.P., et al., “Cessation ofCryptosporidium-Associated Diarrhea in an Acquired Immunodeficiency Syndrome Patient After Treatment with Hyperimmune Bovine Colostrum,” Gastronenterology, 98: 486-489 (1990).
Kovacs-Nolan, Jennifer and Mine, Yoshinori, “Microencapsulation for the Gastric Passage and Controlled Intestinal Release of Immunoglobulin Y,” J. Immunological Methods, 296: 199-209 (2005).
Maiuri, Luigi, et al., “Association Between Innate Response to Gliadin and Activation of Pathogenic T Cells in Coeliac Disease,” The Lancet, 362: 30-37 (2003).
Aleanzi, Mabel, et al., “Celiac Disease: Antibody Recognition against Native and Selectively Deamidated Gliadin Peptides,” Clinical Chem., 47(11): 2023-2028 (2001).
Avaxia Biologics, Inc.
Elmore Carolyn S.
Elmore Patent Law Group PC
Vanstone Darlene A.
Wen Sharon
LandOfFree
Antibody therapy for treatment of diseases associated with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody therapy for treatment of diseases associated with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody therapy for treatment of diseases associated with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4314869